Movatterモバイル変換


[0]ホーム

URL:


US20040117343A1 - Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population - Google Patents

Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population
Download PDF

Info

Publication number
US20040117343A1
US20040117343A1US10/646,578US64657803AUS2004117343A1US 20040117343 A1US20040117343 A1US 20040117343A1US 64657803 AUS64657803 AUS 64657803AUS 2004117343 A1US2004117343 A1US 2004117343A1
Authority
US
United States
Prior art keywords
tissue
indices
specimens
tissue specimens
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/646,578
Inventor
Peter Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioImagene Inc
Cogenics Icoria Inc
Original Assignee
Icoria Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icoria IncfiledCriticalIcoria Inc
Priority to US10/646,578priorityCriticalpatent/US20040117343A1/en
Assigned to PARADIGM GENETICS, INC.reassignmentPARADIGM GENETICS, INC.MERGER (SEE DOCUMENT FOR DETAILS).Assignors: TISSUEINFORMATICS, INC.
Publication of US20040117343A1publicationCriticalpatent/US20040117343A1/en
Assigned to ICORIA, INC.reassignmentICORIA, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: PARADIGM GENETICS, INC.
Assigned to BIOIMAGENE, INC.reassignmentBIOIMAGENE, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: COGENICS, INC.
Abandonedlegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

A sample of normal tissue specimens obtained from a subset of a population of subjects with shared characteristics is profiled in order to generate a plurality of structural indices that correspond to statistically significant representations of characteristics of tissue associated with the population. The structural indices include cell density, matrix density, blood vessel density and layer thickness. Alternatively, the sample of normal tissue specimens obtained from the subset of the population of subjects with shared characteristics can also be profiled in order to generate a plurality of cell function and/or mechanical indices that correspond to statistically significant representations of characteristics of tissue associated with the population. Structural, mechanical and/or cell function indices for a plurality of tissue populations are determined, and then stored in a database. The database information is then used to classify tissue specimens (e.g., human tissue specimens, animal tissue specimens, plant tissue specimens, food tissue specimens, or manufactured tissue specimens) provided by a user. In particular, a user measures parameters (e.g., structural, mechanical and/or cell function indices) associated with the user's tissue specimens and then compares this information to corresponding parameters for normal tissue in the database in order to classify the user's tissue specimens as either normal or abnormal.

Description

Claims (34)

What is claimed is:
1. A computer implemented method for classifying user-supplied tissue specimens, the method comprising:
(A) obtaining tissue specimens for a plurality of tissue types from a subset of a population of subjects with shared characteristics;
(B) imaging each of the tissue specimens;
(C) determining for each tissue type from the imaging in (B) a distribution of values for calculating an average of each of a plurality of structural indices, wherein the plurality of structural indices includes at least one selected from the group consisting of: cell density, matrix density, blood vessel density, layer thickness, relative cell location, relative matrix location and relative blood vessel location;
(D) calculating the average structural indices for the determined distribution of values;
(E) calculating dispersion indices for each of the average indices in (D);
(F) storing the average of each of a plurality structural indices and dispersion indices in a database;
(G) applying steps B-D to measure average structural indices for the user supplied tissue specimens; and
(H) classifying each of the user-supplied tissue specimens as either normal or abnormal by comparing the measured structural indices associated with the user-supplied tissue specimens with the corresponding indices stored in the database, wherein the user-supplied tissue specimens are classified as abnormal to the extent that there is a statistically significant deviation of the measured indices from the indices stored in the database,
wherein the number of tissue specimens in (A) includes a sufficient number of specimens such that the indices correspond to a statistically significant representation of those indices for the population as a whole.
2. The method ofclaim 1, wherein the at least one is the cell density.
3. The method ofclaim 1, wherein the at least one is the matrix density.
4. The method ofclaim 1, wherein the tissue specimens comprise normal tissue.
5. The method ofclaim 1, wherein the tissue specimens comprise abnormal tissue.
6. The method ofclaim 1, wherein the tissue specimens comprise normal and abnormal tissue of the same tissue type, and
wherein in the determination of distribution of values and corresponding index, data from normal tissue is used to determine a distribution of values and a corresponding index for normal tissue and data from abnormal tissue is used to determine a distribution of values and a corresponding index for abnormal tissue.
7. The method ofclaim 1, wherein the given plurality of tissue types includes at least one type selected from the group consisting of skin, liver, kidney, muscle, brain and pancreas.
8. The method ofclaim 1, wherein the plurality of structural indices includes at least two selected from the group consisting of: cell density, matrix density, blood vessel density, layer thickness, relative cell location, relative matrix location and relative blood vessel location.
9. The method ofclaim 8, where the at least two are the cell density and matrix density.
10. The method ofclaim 8, wherein the tissue specimens comprise normal and abnormal tissue of the same tissue type, and
wherein in the determination of distribution of values and corresponding index, data from normal tissue is used to determine a distribution of values and a corresponding index for normal tissue and data from abnormal tissue is used to determine a distribution of values and a corresponding index for abnormal tissue.
11. The method ofclaim 8, wherein the given plurality of tissue types includes at least one type selected from the group consisting of skin, liver, kidney, muscle, brain and pancreas.
12. A computer implemented method for classifying user-supplied tissue specimens, the method comprising:
(A) obtaining tissue specimens for a plurality of tissue types from a subset of a population of subjects with shared characteristics;
(B) analyzing each of the tissue specimens;
(C) determining for each tissue type from the analysis in (B) a distribution of values for calculating an average of each of a plurality of cell function indices, wherein the given plurality of cell function indices includes at least one selected from the group consisting of: location, type and amount of DNA; location, type and amount of mRNA; location, type and amount of cellular proteins; location, type and amount of cellular lipids; and location, type and amount of cellular ion distributions;
(D) calculating the average cell function indices for the determined distribution of values;
(E) storing the average cell function indices in a database;
(F) applying steps B-D to measure average cell function indices for the user supplied tissue specimens; and
(G) classifying each of the user-supplied tissue specimens as either normal or abnormal by comparing the measured cell function indices associated with the user-supplied tissue specimens with the corresponding cell function indices stored in the database, wherein the user-supplied tissue specimens are classified as abnormal to the extent that there is a statistically significant deviation of the measured cell function indices from the cell function indices stored in the database,
wherein the number of tissue specimens in (A) includes a sufficient number of specimens such that the indices correspond to a statistically significant representation of those indices for the population as a whole.
13. The method ofclaim 12, wherein the at least one is the location, type and amount of cellular proteins.
14. The method ofclaim 12, wherein the tissue specimens comprise normal tissue
15. The method ofclaim 12, wherein the tissue specimens comprise abnormal tissue
16. The method ofclaim 12, wherein the tissue specimens comprise normal and abnormal tissue of the same tissue type, and
wherein in the determination of distribution of values and corresponding index, data from normal tissue is used to determine a distribution of values and a corresponding index for normal tissue and data from abnormal tissue is used to determine a distribution of values and a corresponding index for abnormal tissue.
17. The method ofclaim 12, wherein the given plurality of tissue types includes at least one type selected from the group consisting of skin, liver, kidney, muscle, brain and pancreas.
18. The method ofclaim 12, wherein the given plurality of cell function indices includes at least two indices selected from the group consisting of: location, type and amount of DNA; location, type and amount of mRNA; location, type and amount of cellular proteins; location, type and amount of cellular lipids; and location, type and amount of cellular ion distributions.
19. The method ofclaim 18, wherein the at least two are the location, type and amount of DNA, and the location, type and amount of mRNA.
20. The method ofclaim 18, wherein the tissue specimens comprise normal and abnormal tissue of the same tissue type, and
wherein in the determination of distribution of values and corresponding index, data from normal tissue is used to determine a distribution of values and a corresponding index for normal tissue and data from abnormal tissue is used to determine a distribution of values and a corresponding index for abnormal tissue.
21. The method ofclaim 18, wherein the given plurality of tissue types includes at least one type selected from the group consisting of skin, liver, kidney, muscle, brain and pancreas.
22. A computer implemented method for classifying user-supplied tissue specimens, the method comprising:
(A) obtaining tissue specimens for a plurality of tissue types from a subset of a population of subjects with shared characteristics,
(B) analyzing each of the tissue specimens,
(C) determining for each tissue type from the analysis in (B) a distribution of values for calculating an average of each of a plurality of mechanical indices, wherein the given plurality of mechanical indices includes at least one selected from the group consisting of modulus of elasticity and mechanical strength;
(D) calculating the average mechanical indices for the determined distribution of values;
(E) storing the average mechanical indices in a database;
(F) applying steps B-D to measure average mechanical indices for the user supplied tissue specimens; and
(G) classifying each of the user-supplied tissue specimens as either normal or abnormal by comparing the measured average mechanical indices associated with the user-supplied tissue specimens with the corresponding indices stored in the database, wherein the user-supplied tissue specimens are classified as abnormal to the extent that there is a statistically significant deviation of the measured mechanical indices from the indices stored in the database,
wherein the number of tissue specimens in (A) includes a sufficient number of specimens such that the indices correspond to a statistically significant representation of those indices for the population as a whole.
23. The method ofclaim 22, wherein the tissue specimens comprise normal tissue.
24. The method ofclaim 22, wherein the tissue specimens comprise abnormal tissue.
25. The method ofclaim 22, wherein the tissue specimens comprise normal and abnormal tissue of the same tissue type, and
wherein in the determination of distribution of values and corresponding index, data from normal tissue is used to determine a distribution of values and a corresponding index for normal tissue and data from abnormal tissue is used to determine a distribution of values and a corresponding index for abnormal tissue.
26. The method ofclaim 22, wherein the given plurality of tissue types includes at least one type selected from the group consisting of skin, liver, kidney, muscle, brain and pancreas.
27. A computer implemented method for assessing normalcy of user-supplied tissue specimens, the method comprising:
(A) obtaining tissue specimens for a plurality of tissue types from a subset of a population of subjects with shared characteristics;
(B) imaging each of the tissue specimens;
(C) determining for each tissue type from the imaging in (B) a distribution of values for calculating an average of each of a plurality of structural indices, wherein the plurality of structural indices includes at least one selected from the group consisting of: cell density, matrix density, blood vessel density, layer thickness, relative cell location, relative matrix location and relative blood vessel location;
(D) calculating the average structural indices for the determined distribution of values;
(E) calculating dispersion indices for each of the average indices in (D);
(F) storing the average of each of a plurality structural indices and dispersion indices in a database;
(G) applying steps B-D to measure average structural indices for the user supplied tissue specimens; and
(H) assessing the normalcy of each of the user-supplied tissue specimens by comparing the measured structural indices associated with the user-supplied tissue specimens with the corresponding indices stored in the database.
wherein the number of tissue specimens in (A) includes a sufficient number of specimens such that the indices correspond to a statistically significant representation of those indices for the population as a whole.
28. The method ofclaim 27, wherein in step (H) the user-supplied tissue specimens are classified as abnormal to the extent that there is a statistically significant deviation of the measured indices from the indices stored in the database.
29. A computer implemented method for assessing normalcy of user-supplied tissue specimens, the method comprising:
(A) obtaining tissue specimens for a plurality of tissue types from a subset of a population of subjects with shared characteristics;
(B) analyzing each of the tissue specimens;
(C) determining for each tissue type from the analysis in (B) a distribution of values for calculating an average of each of a plurality of cell function indices, wherein the given plurality of cell function indices includes at least one selected from the group consisting of: location, type and amount of DNA; location, type and amount of mRNA; location, type and amount of cellular proteins; location, type and amount of cellular lipids; and location, type and amount of cellular ion distributions;
(D) calculating the average cell function indices for the determined distribution of values;
(E) storing the average cell function indices in a database;
(F) applying steps B-D to measure average cell function indices for the user supplied tissue specimens; and
(G) assessing the normalcy of the user-supplied tissue specimens by comparing the measured cell function indices associated with the user-supplied tissue specimens with the corresponding cell function indices stored in the database,
wherein the number of tissue specimens in (A) includes a sufficient number of specimens such that the indices correspond to a statistically significant representation of those indices for the population as a whole.
30. The method ofclaim 29, wherein in step (H) the user-supplied tissue specimens are classified as abnormal to the extent that there is a statistically significant deviation of the measured cell function indices from the cell function indices stored in the database.
31. A computer implemented method for assessing normalcy of user-supplied tissue specimens, the method comprising:
(A) obtaining tissue specimens for a plurality of tissue types from a subset of a population of subjects with shared characteristics,
(B) analyzing each of the tissue specimens,
(C) determining for each tissue type from the analysis in (B) a distribution of values for calculating an average of each of a plurality of mechanical indices, wherein the given plurality of mechanical indices includes at least one selected from the group consisting of modulus of elasticity and mechanical strength;
(D) calculating the average mechanical indices for the determined distribution of values;
(E) storing the average mechanical indices in a database;
(F) applying steps B-D to measure average mechanical indices for the user supplied tissue specimens; and
(G) assessing the normalcy of each of the user-supplied tissue specimens by comparing the measured average mechanical indices associated with the user-supplied tissue specimens with the corresponding indices stored in the database,
wherein the number of tissue specimens in (A) includes a sufficient number of specimens such that the indices correspond to a statistically significant representation of those indices for the population as a whole.
32. The method ofclaim 31, wherein in step (H) the user-supplied tissue specimens are classified as abnormal to the extent that there is a statistically significant deviation of the measured mechanical indices from the indices stored in the database.
33. A computer program product embodied in one or more computer-readable storage mediums and for classifying user-supplied tissue specimens, the computer program product comprising:
code for generating values corresponding to a sample of tissue specimens of a given tissue type to generate values for each of said tissue specimens in the sample, wherein the given tissue type corresponds to a population of subjects having at least one shared characteristic;
code for determining at least one index for each of said tissue specimens using said values, wherein each said at least one index corresponds to a statistically significant representation of said values from which it is determined;
code for storing said determined indices; and,
code for providing access to said stored indices so as to allow said at least one user to obtain said information representative of a plurality of tissue types.
34. A computer program product embodied in one or more computer-readable storage mediums and for classifying user-supplied tissue specimens, the computer program product comprising:
code for generating values corresponding to a sample of tissue specimens of a given tissue type to generate values for each of said tissue specimens in the sample, wherein the given tissue type corresponds to a population of subjects having at least one shared characteristic;
code for calculating a plurality of indices for each of said tissue specimens using said values, wherein each said at least one index corresponds to a statistically significant representation of said values from which it is determined;
code for storing said calculated indices; and
code for providing access to said stored indices so as to allow said at least one user to obtain said information representative of a plurality of tissue types.
US10/646,5781999-06-232003-08-22Methods for profiling and classifying tissue using a database that includes indices representative of a tissue populationAbandonedUS20040117343A1 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US10/646,578US20040117343A1 (en)1999-06-232003-08-22Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US09/338,909US6611833B1 (en)1999-06-231999-06-23Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population
US10/646,578US20040117343A1 (en)1999-06-232003-08-22Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population

Related Parent Applications (1)

Application NumberTitlePriority DateFiling Date
US09/338,909ContinuationUS6611833B1 (en)1999-06-231999-06-23Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population

Publications (1)

Publication NumberPublication Date
US20040117343A1true US20040117343A1 (en)2004-06-17

Family

ID=23326653

Family Applications (2)

Application NumberTitlePriority DateFiling Date
US09/338,909Expired - LifetimeUS6611833B1 (en)1999-06-231999-06-23Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population
US10/646,578AbandonedUS20040117343A1 (en)1999-06-232003-08-22Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
US09/338,909Expired - LifetimeUS6611833B1 (en)1999-06-231999-06-23Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population

Country Status (6)

CountryLink
US (2)US6611833B1 (en)
EP (1)EP1194775A4 (en)
JP (1)JP2003502669A (en)
AU (1)AU5888000A (en)
CA (1)CA2389220C (en)
WO (1)WO2000079269A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20110054357A1 (en)*2009-09-022011-03-03Artann Laboratories, Inc.Methods for characterizing vaginal tissue elasticity
US9955910B2 (en)2005-10-142018-05-01Aranz Healthcare LimitedMethod of monitoring a surface feature and apparatus therefor
US10013527B2 (en)2016-05-022018-07-03Aranz Healthcare LimitedAutomatically assessing an anatomical surface feature and securely managing information related to the same
US10874302B2 (en)2011-11-282020-12-29Aranz Healthcare LimitedHandheld skin measuring or monitoring device
US11116407B2 (en)2016-11-172021-09-14Aranz Healthcare LimitedAnatomical surface assessment methods, devices and systems
US11903723B2 (en)2017-04-042024-02-20Aranz Healthcare LimitedAnatomical surface assessment methods, devices and systems
US12039726B2 (en)2019-05-202024-07-16Aranz Healthcare LimitedAutomated or partially automated anatomical surface assessment methods, devices and systems

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6993170B2 (en)*1999-06-232006-01-31Icoria, Inc.Method for quantitative analysis of blood vessel structure
US20020087511A1 (en)*1999-09-022002-07-04Johnson Peter C.Methods for profiling and manufacturing tissue using a database that includes indices representative of a tissue population
US7613571B2 (en)*2000-07-282009-11-03Doyle Michael DMethod and system for the multidimensional morphological reconstruction of genome expression activity
JP2002172117A (en)*2000-09-052002-06-18Fuji Photo Film Co LtdOutput device of optical tomographic image diagnostic information
US7231243B2 (en)2000-10-302007-06-12The General Hospital CorporationOptical methods for tissue analysis
US9295391B1 (en)2000-11-102016-03-29The General Hospital CorporationSpectrally encoded miniature endoscopic imaging probe
AT503309B1 (en)2001-05-012011-08-15Gen Hospital Corp DEVICE FOR DETERMINING ATHEROSCLEROTIC BEARING BY MEASURING OPTICAL TISSUE PROPERTIES
KR100452748B1 (en)*2001-05-082004-10-12유닉스전자주식회사A detect method of electro-cardiogram using the electric tonometer
EP1277842B1 (en)*2001-07-172008-10-29FUJIFILM CorporationMethod for quantifying nucleic acid by cell counting
US7355716B2 (en)2002-01-242008-04-08The General Hospital CorporationApparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US8054468B2 (en)2003-01-242011-11-08The General Hospital CorporationApparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
CA2514189A1 (en)*2003-01-242004-08-12The General Hospital CorporationSystem and method for identifying tissue using low-coherence interferometry
EP2436307B1 (en)2003-03-312015-10-21The General Hospital CorporationSpeckle reduction in optical coherence tomography by path length encoded angular compounding
KR101386971B1 (en)2003-06-062014-04-18더 제너럴 하스피탈 코포레이션Process and apparatus for a wavelength tunning source
US20050014131A1 (en)*2003-07-162005-01-20Cytokinetics, Inc.Methods and apparatus for investigating side effects
US7505948B2 (en)*2003-11-182009-03-17Aureon Laboratories, Inc.Support vector regression for censored data
US7467119B2 (en)*2003-07-212008-12-16Aureon Laboratories, Inc.Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
EP2280256B1 (en)2003-10-272016-11-16The General Hospital CorporationMethod and apparatus for performing optical imaging using frequency-domain interferometry
WO2005050563A2 (en)*2003-11-172005-06-02Aureon Biosciences CorporationPathological tissue mapping
WO2005086068A2 (en)*2004-02-272005-09-15Aureon Laboratories, Inc.Methods and systems for predicting occurrence of an event
KR101239250B1 (en)2004-05-292013-03-05더 제너럴 하스피탈 코포레이션Process, system and software arrangement for a chromatic dispersion compensation using reflective layers in optical coherence tomography (oct) imaging
AU2005270037B2 (en)*2004-07-022012-02-09The General Hospital CorporationEndoscopic imaging probe comprising dual clad fibre
EP1782020B1 (en)2004-08-062012-10-03The General Hospital CorporationProcess, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
CA2575859A1 (en)*2004-08-112006-02-23Aureon Laboratories, Inc.Systems and methods for automated diagnosis and grading of tissue images
WO2006024014A2 (en)2004-08-242006-03-02The General Hospital CorporationProcess, system and software arrangement for measuring a mechanical strain and elastic properties of a sample
EP2272421A1 (en)2004-08-242011-01-12The General Hospital CorporationMethod and apparatus for imaging of vessel segments
US7365859B2 (en)2004-09-102008-04-29The General Hospital CorporationSystem and method for optical coherence imaging
KR101257100B1 (en)2004-09-292013-04-22더 제너럴 하스피탈 코포레이션System and Method for Optical Coherence Imaging
WO2006058049A1 (en)2004-11-242006-06-01The General Hospital CorporationCommon-path interferometer for endoscopic oct
WO2006058346A1 (en)2004-11-292006-06-01The General Hospital CorporationArrangements, devices, endoscopes, catheters and methods for performing optical imaging by simultaneously illuminating and detecting multiple points on a sample
ES2337497T3 (en)*2005-04-282010-04-26The General Hospital Corporation EVALUATION OF CHARACTERISTICS OF THE IMAGE OF AN ANATOMICAL STRUCTURE IN IMAGES OF TOMOGRAPHY OF OPTICAL COHERENCE.
US9060689B2 (en)2005-06-012015-06-23The General Hospital CorporationApparatus, method and system for performing phase-resolved optical frequency domain imaging
EP2267404B1 (en)2005-08-092016-10-05The General Hospital CorporationApparatus and method for performing polarization-based quadrature demodulation in optical coherence tomography
JP4647442B2 (en)*2005-09-142011-03-09独立行政法人情報通信研究機構 Data display device, data display method, and data display program
US7843572B2 (en)2005-09-292010-11-30The General Hospital CorporationMethod and apparatus for optical imaging via spectral encoding
US7889348B2 (en)2005-10-142011-02-15The General Hospital CorporationArrangements and methods for facilitating photoluminescence imaging
EP1971848B1 (en)2006-01-102019-12-04The General Hospital CorporationSystems and methods for generating data based on one or more spectrally-encoded endoscopy techniques
US7783092B2 (en)*2006-01-172010-08-24Illinois Institute Of TechnologyMethod for enhancing diagnostic images using vessel reconstruction
US8145018B2 (en)2006-01-192012-03-27The General Hospital CorporationApparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and methods for producing one or more optical arrangements
DK1973466T3 (en)2006-01-192021-02-01Massachusetts Gen Hospital BALLOON IMAGING CATHETER
JP5680829B2 (en)2006-02-012015-03-04ザ ジェネラル ホスピタル コーポレイション A device that irradiates a sample with multiple electromagnetic radiations
WO2007149602A2 (en)2006-02-012007-12-27The General Hospital CorporationMethods and systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures
US9777053B2 (en)2006-02-082017-10-03The General Hospital CorporationMethods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
EP2982929A1 (en)2006-02-242016-02-10The General Hospital CorporationMethods and systems for performing angle-resolved fourier-domain optical coherence tomography
WO2007133961A2 (en)2006-05-102007-11-22The General Hospital CorporationProcesses, arrangements and systems for providing frequency domain imaging of a sample
US7920271B2 (en)2006-08-252011-04-05The General Hospital CorporationApparatus and methods for enhancing optical coherence tomography imaging using volumetric filtering techniques
US8838213B2 (en)2006-10-192014-09-16The General Hospital CorporationApparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s)
EP2104968A1 (en)2007-01-192009-09-30The General Hospital CorporationRotating disk reflection for fast wavelength scanning of dispersed broadband light
US9176319B2 (en)2007-03-232015-11-03The General Hospital CorporationMethods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures
US10534129B2 (en)2007-03-302020-01-14The General Hospital CorporationSystem and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque
US8045177B2 (en)2007-04-172011-10-25The General Hospital CorporationApparatus and methods for measuring vibrations using spectrally-encoded endoscopy
US9375158B2 (en)2007-07-312016-06-28The General Hospital CorporationSystems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging
US7933021B2 (en)2007-10-302011-04-26The General Hospital CorporationSystem and method for cladding mode detection
US8249696B2 (en)2007-12-192012-08-21Depuy Spine, Inc.Smart pedicle tool
US7898656B2 (en)2008-04-302011-03-01The General Hospital CorporationApparatus and method for cross axis parallel spectroscopy
EP2274572A4 (en)2008-05-072013-08-28Gen Hospital Corp SYSTEM, METHOD AND COMPUTER MEDIUM FOR MONITORING THE MOVEMENT OF VESSELS DURING A THREE-DIMENSIONAL MICROSCOPY EXAMINATION OF CORONARY ARTERIES
KR100963689B1 (en)2008-05-132010-06-15대한민국 How to classify human tissue
US8861910B2 (en)2008-06-202014-10-14The General Hospital CorporationFused fiber optic coupler arrangement and method for use thereof
WO2010009136A2 (en)2008-07-142010-01-21The General Hospital CorporationApparatus and methods for color endoscopy
WO2010039255A2 (en)*2008-10-032010-04-08Hlz Innovation, LlcAdjustable pneumatic supporting surface
JP5731394B2 (en)2008-12-102015-06-10ザ ジェネラル ホスピタル コーポレイション System, apparatus and method for extending imaging depth range of optical coherence tomography through optical subsampling
JP2012515576A (en)2009-01-202012-07-12ザ ジェネラル ホスピタル コーポレイション Endoscopic biopsy device, system, and method
US8097864B2 (en)2009-01-262012-01-17The General Hospital CorporationSystem, method and computer-accessible medium for providing wide-field superresolution microscopy
CA2749670A1 (en)2009-02-042010-08-12The General Hospital CorporationApparatus and method for utilization of a high-speed optical wavelength tuning source
JP5819823B2 (en)2009-07-142015-11-24ザ ジェネラル ホスピタル コーポレイション Device for measuring the flow and pressure inside a blood vessel and method of operating the device
WO2011100430A2 (en)2010-02-102011-08-18Kickstart International, Inc.Human-powered irrigation pump
KR20130004326A (en)2010-03-052013-01-09더 제너럴 하스피탈 코포레이션Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US9069130B2 (en)2010-05-032015-06-30The General Hospital CorporationApparatus, method and system for generating optical radiation from biological gain media
EP2575598A2 (en)2010-05-252013-04-10The General Hospital CorporationApparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images
EP2575597B1 (en)2010-05-252022-05-04The General Hospital CorporationApparatus for providing optical imaging of structures and compositions
JP6066901B2 (en)2010-06-032017-01-25ザ ジェネラル ホスピタル コーポレイション Method for apparatus and device for imaging structures in or in one or more luminal organs
WO2012058381A2 (en)2010-10-272012-05-03The General Hospital CorporationApparatus, systems and methods for measuring blood pressure within at least one vessel
US20120207360A1 (en)*2011-02-112012-08-16Courosh MehanianSystems and Methods for Object Identification
US9330092B2 (en)2011-07-192016-05-03The General Hospital CorporationSystems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography
EP3835718B1 (en)2011-08-252023-07-26The General Hospital CorporationApparatus for providing micro-optical coherence tomography inside a respiratory system
JP2015502562A (en)2011-10-182015-01-22ザ ジェネラル ホスピタル コーポレイション Apparatus and method for generating and / or providing recirculating optical delay
WO2013148306A1 (en)2012-03-302013-10-03The General Hospital CorporationImaging system, method and distal attachment for multidirectional field of view endoscopy
JP2015517387A (en)2012-05-212015-06-22ザ ジェネラル ホスピタル コーポレイション Apparatus, device and method for capsule microscopy
JP6227652B2 (en)2012-08-222017-11-08ザ ジェネラル ホスピタル コーポレイション System, method, and computer-accessible medium for fabricating a miniature endoscope using soft lithography
US9968261B2 (en)2013-01-282018-05-15The General Hospital CorporationApparatus and method for providing diffuse spectroscopy co-registered with optical frequency domain imaging
WO2014120791A1 (en)2013-01-292014-08-07The General Hospital CorporationApparatus, systems and methods for providing information regarding the aortic valve
US11179028B2 (en)2013-02-012021-11-23The General Hospital CorporationObjective lens arrangement for confocal endomicroscopy
US10478072B2 (en)2013-03-152019-11-19The General Hospital CorporationMethods and system for characterizing an object
EP2997354A4 (en)2013-05-132017-01-18The General Hospital CorporationDetecting self-interefering fluorescence phase and amplitude
EP3021735A4 (en)2013-07-192017-04-19The General Hospital CorporationDetermining eye motion by imaging retina. with feedback
WO2015009932A1 (en)2013-07-192015-01-22The General Hospital CorporationImaging apparatus and method which utilizes multidirectional field of view endoscopy
WO2015013651A2 (en)2013-07-262015-01-29The General Hospital CorporationSystem, apparatus and method utilizing optical dispersion for fourier-domain optical coherence tomography
WO2015105870A1 (en)2014-01-082015-07-16The General Hospital CorporationMethod and apparatus for microscopic imaging
US10736494B2 (en)2014-01-312020-08-11The General Hospital CorporationSystem and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device
WO2015153982A1 (en)2014-04-042015-10-08The General Hospital CorporationApparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s)
US10912462B2 (en)2014-07-252021-02-09The General Hospital CorporationApparatus, devices and methods for in vivo imaging and diagnosis

Citations (17)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5506098A (en)*1991-09-041996-04-09Daikin Industries, Ltd.In situ hybridization method
US5526258A (en)*1990-10-101996-06-11Cell Analysis System, Inc.Method and apparatus for automated analysis of biological specimens
US5640453A (en)*1994-08-111997-06-17Stanford Telecommunications, Inc.Universal interactive set-top controller for downloading and playback of information and entertainment services
US5668634A (en)*1992-07-031997-09-16Newman; Paul Bernard DavidQuality control and grading system for meat
US5685313A (en)*1994-05-311997-11-11Brain Monitor Ltd.Tissue monitor
US5713364A (en)*1995-08-011998-02-03Medispectra, Inc.Spectral volume microprobe analysis of materials
US5785663A (en)*1992-12-211998-07-28Artann CorporationMethod and device for mechanical imaging of prostate
US5836872A (en)*1989-04-131998-11-17Vanguard Imaging, Ltd.Digital optical visualization, enhancement, quantification, and classification of surface and subsurface features of body surfaces
US5891619A (en)*1997-01-141999-04-06Inphocyte, Inc.System and method for mapping the distribution of normal and abnormal cells in sections of tissue
US5933519A (en)*1994-09-201999-08-03Neo Path, Inc.Cytological slide scoring apparatus
US5987346A (en)*1993-02-261999-11-16Benaron; David A.Device and method for classification of tissue
US6026174A (en)*1992-10-142000-02-15Accumed International, Inc.System and method for automatically detecting malignant cells and cells having malignancy-associated changes
US6081612A (en)*1997-02-282000-06-27Electro Optical Sciences Inc.Systems and methods for the multispectral imaging and characterization of skin tissue
US6104835A (en)*1997-11-142000-08-15Kla-Tencor CorporationAutomatic knowledge database generation for classifying objects and systems therefor
US6136955A (en)*1997-05-092000-10-24Incyte Pharmaceuticals, Inc.Human SMT3-like protein
US6238342B1 (en)*1998-05-262001-05-29Riverside Research InstituteUltrasonic tissue-type classification and imaging methods and apparatus
US6246785B1 (en)*1996-04-272001-06-12Roche Diagnostics GmbhAutomated, microscope-assisted examination process of tissue or bodily fluid samples

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JP3139085B2 (en)*1991-11-072001-02-26株式会社ニコン Apparatus and method for determining ion concentration
US5293772A (en)*1992-01-171994-03-15Center For Innovative TechnologyInstrumentation and method for evaluating platelet performance during clotting and dissolution of blood clots and for evaluating erythrocyte flexibility
JPH0694706A (en)*1992-09-101994-04-08Sumitomo Metal Ind Ltd Pathological image inspection support device
EP0592997A3 (en)*1992-10-161994-11-17Becton Dickinson CoMethods and apparatus for measuring tissue section thickness.
NZ294720A (en)*1995-01-271998-06-26Incyte Pharma IncComputer system storing and analyzing microbiological data
US5733739A (en)*1995-06-071998-03-31Inphocyte, Inc.System and method for diagnosis of disease by infrared analysis of human tissues and cells
US5837283A (en)*1997-03-121998-11-17The Regents Of The University Of CaliforniaCationic lipid compositions targeting angiogenic endothelial cells
US5993844A (en)*1997-05-081999-11-30Organogenesis, Inc.Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
JPH1119077A (en)*1997-06-301999-01-26Konica CorpMethod and device for detection of tumor shadow in radiation image

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5836872A (en)*1989-04-131998-11-17Vanguard Imaging, Ltd.Digital optical visualization, enhancement, quantification, and classification of surface and subsurface features of body surfaces
US5526258A (en)*1990-10-101996-06-11Cell Analysis System, Inc.Method and apparatus for automated analysis of biological specimens
US5506098A (en)*1991-09-041996-04-09Daikin Industries, Ltd.In situ hybridization method
US5668634A (en)*1992-07-031997-09-16Newman; Paul Bernard DavidQuality control and grading system for meat
US6026174A (en)*1992-10-142000-02-15Accumed International, Inc.System and method for automatically detecting malignant cells and cells having malignancy-associated changes
US5785663A (en)*1992-12-211998-07-28Artann CorporationMethod and device for mechanical imaging of prostate
US5987346A (en)*1993-02-261999-11-16Benaron; David A.Device and method for classification of tissue
US5685313A (en)*1994-05-311997-11-11Brain Monitor Ltd.Tissue monitor
US5640453A (en)*1994-08-111997-06-17Stanford Telecommunications, Inc.Universal interactive set-top controller for downloading and playback of information and entertainment services
US5933519A (en)*1994-09-201999-08-03Neo Path, Inc.Cytological slide scoring apparatus
US5713364A (en)*1995-08-011998-02-03Medispectra, Inc.Spectral volume microprobe analysis of materials
US6246785B1 (en)*1996-04-272001-06-12Roche Diagnostics GmbhAutomated, microscope-assisted examination process of tissue or bodily fluid samples
US5891619A (en)*1997-01-141999-04-06Inphocyte, Inc.System and method for mapping the distribution of normal and abnormal cells in sections of tissue
US6081612A (en)*1997-02-282000-06-27Electro Optical Sciences Inc.Systems and methods for the multispectral imaging and characterization of skin tissue
US6136955A (en)*1997-05-092000-10-24Incyte Pharmaceuticals, Inc.Human SMT3-like protein
US6104835A (en)*1997-11-142000-08-15Kla-Tencor CorporationAutomatic knowledge database generation for classifying objects and systems therefor
US6238342B1 (en)*1998-05-262001-05-29Riverside Research InstituteUltrasonic tissue-type classification and imaging methods and apparatus

Cited By (15)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US10827970B2 (en)2005-10-142020-11-10Aranz Healthcare LimitedMethod of monitoring a surface feature and apparatus therefor
US9955910B2 (en)2005-10-142018-05-01Aranz Healthcare LimitedMethod of monitoring a surface feature and apparatus therefor
US8052622B2 (en)*2009-09-022011-11-08Artann Laboratories IncMethods for characterizing vaginal tissue elasticity
US20110054357A1 (en)*2009-09-022011-03-03Artann Laboratories, Inc.Methods for characterizing vaginal tissue elasticity
US11850025B2 (en)2011-11-282023-12-26Aranz Healthcare LimitedHandheld skin measuring or monitoring device
US10874302B2 (en)2011-11-282020-12-29Aranz Healthcare LimitedHandheld skin measuring or monitoring device
US10777317B2 (en)2016-05-022020-09-15Aranz Healthcare LimitedAutomatically assessing an anatomical surface feature and securely managing information related to the same
US11250945B2 (en)2016-05-022022-02-15Aranz Healthcare LimitedAutomatically assessing an anatomical surface feature and securely managing information related to the same
US10013527B2 (en)2016-05-022018-07-03Aranz Healthcare LimitedAutomatically assessing an anatomical surface feature and securely managing information related to the same
US11923073B2 (en)2016-05-022024-03-05Aranz Healthcare LimitedAutomatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en)2016-11-172021-09-14Aranz Healthcare LimitedAnatomical surface assessment methods, devices and systems
US12268472B2 (en)2016-11-172025-04-08ARANZ Medical LimitedAnatomical surface assessment methods, devices and systems
US11903723B2 (en)2017-04-042024-02-20Aranz Healthcare LimitedAnatomical surface assessment methods, devices and systems
US12279883B2 (en)2017-04-042025-04-22ARANZ Medical LimitedAnatomical surface assessment methods, devices and systems
US12039726B2 (en)2019-05-202024-07-16Aranz Healthcare LimitedAutomated or partially automated anatomical surface assessment methods, devices and systems

Also Published As

Publication numberPublication date
US6611833B1 (en)2003-08-26
WO2000079269A1 (en)2000-12-28
CA2389220A1 (en)2000-12-28
EP1194775A1 (en)2002-04-10
AU5888000A (en)2001-01-09
EP1194775A4 (en)2004-09-15
JP2003502669A (en)2003-01-21
CA2389220C (en)2011-07-26

Similar Documents

PublicationPublication DateTitle
US6611833B1 (en)Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population
US6581011B1 (en)Online database that includes indices representative of a tissue population
Jang et al.Heritability of facet-level traits in a cross-cultural twin sample: support for a hierarchical model of personality.
Dyce et al.Personality disorders and the five-factor model: A test of facet-level predictions
Kendziorski et al.The efficiency of pooling mRNA in microarray experiments
Davis et al.Psychosocial adjustment to and control of diabetes mellitus: differences by disease type and treatment.
Funk et al.Testing the ruler with item response theory: increasing precision of measurement for relationship satisfaction with the Couples Satisfaction Index.
Wittkowski et al.Combining several ordinal measures in clinical studies
Michels et al.Progression of familial and non-familial dilated cardiomyopathy: long term follow up
EP1498825A1 (en)Apparatus and method for analyzing data
WO2002044715A1 (en)Methods for efficiently minig broad data sets for biological markers
JP7527071B2 (en) Automatic reporting system for gene mutation test results that is updated periodically
CN112470229A (en)Computer-implemented method of analyzing genetic data about an organism
US20240087677A1 (en)Method for analysis of omics data
CN113345592A (en)Construction and diagnosis equipment for acute myeloid leukemia prognosis risk model
HopperThe epidemiology of genetic epidemiology
BrunerThe brain, the braincase, and the morphospace
Sunderland et al.Efficiently measuring dimensions of the externalizing spectrum model: Development of the Externalizing Spectrum Inventory-Computerized Adaptive Test (ESI-CAT).
Reiner-Benaim et al.Associating quantitative behavioral traits with gene expression in the brain: searching for diamonds in the hay
CN113838519B (en) Gene selection method and system based on adaptive gene interaction regularization elastic network model
US20020087511A1 (en)Methods for profiling and manufacturing tissue using a database that includes indices representative of a tissue population
Delmar et al.Mixture model on the variance for the differential analysis of gene expression data
Zhong et al.Cell segmentation and gene imputation for imaging-based spatial transcriptomics
Bowman et al.Methods for detecting functional classifications in neuroimaging data
WO2000079270A1 (en)Methods for profiling and manufacturing tissue using a database that includes indices representative of a tissue population

Legal Events

DateCodeTitleDescription
ASAssignment

Owner name:PARADIGM GENETICS, INC., NORTH CAROLINA

Free format text:MERGER;ASSIGNOR:TISSUEINFORMATICS, INC.;REEL/FRAME:014669/0544

Effective date:20040311

ASAssignment

Owner name:ICORIA, INC., NORTH CAROLINA

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PARADIGM GENETICS, INC.;REEL/FRAME:015065/0876

Effective date:20040417

STCBInformation on status: application discontinuation

Free format text:ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

ASAssignment

Owner name:BIOIMAGENE, INC., CALIFORNIA

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:COGENICS, INC.;REEL/FRAME:021531/0746

Effective date:20080822


[8]ページ先頭

©2009-2025 Movatter.jp